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Sildena®l citrate is well known as Viagra for the treatment of
erectile dysfuncion. In the title compound (systematic name:
1-{[3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-
d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl}-4-methylpiperaz-
inium citrate monohydrate), C22H31N6O4S
+C6H7O7ÿH2O,
the pyrazolopyrimidone ring system and the benzene ring are
almost coplanar, enabling an intramolecular hydrogen bond
between the pyrazolopyrimidone NH group and the O atom
of the ethoxy group. One of the N atoms of the piperazine ring
is protonated and the citrate molecule exists as an anion. The
crystal packing is stabilized by several hydrogen bonds.
Comment
Sildena®l citrate is used to treat male erectile dysfunction
under the trade name Viagra. The parent base, sildena®l, is a
potent selective inhibitor of the enzyme phosphodiesterase
(PDE-5), which destroys cyclic guanosine monophosphate
(cGMP), itself a dilator of blood vessels in the body (Terrett et
al., 1996). The discovery and development of sildena®l has
been a revolutionary event in medicine and society. A detailed
review of sildena®l citrate has been published by McCullough
(2002).
A perspective view of the title compound, (I), the mono-
hydrate of sildena®l citrate, is shown in Fig. 1. Bond lengths
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and angles can be regarded as normal (Cambridge Structural
Database, Version 1.6 plus three updates; MOGUL Version
1.0; Allen, 2002). The piperazine ring shows the expected chair
conformation, with the methyl and sulfonyl groups attached
equatorially. The propyl and ethoxy side chains are in a trans
conformation.
The crystal structure of isosildena®l, an isomeric compound
of sildena®l, methylated at N2 of the pyrazolopyrimidone ring
system, has been reported by El-Abadelah et al. (1999). The
main difference between (I) and isosildena®l is that in the
sildena®l cation of (I), the pyrazolopyrimidone ring system
and the benzene ring are almost coplanar. The dihedral angle
between the two cyclic groups is 11.6 (3), whereas this angle is
43.3 (1) in isosildena®l. As a result, in (I), there is a hydrogen
bond between the pyrazolopyrimidone NH group and the O
atom of the ethoxy group (Table 2). In isosildena®l, however,
this interaction is signi®cantly weaker (NÐH = 0.95 AÊ , H  O
= 2.35 AÊ , N  O = 2.767 AÊ and NÐH  O 106.1). Further-
more, the conformation of the propyl chains differ. The
conformation is trans [ÿ173.4 (6)] in (I) and gauche in
isosildena®l [ÿ60.6 (7)]. A least-squares ®t of (I) with
isosildena®l is shown in Fig. 2. Apart from the intramolecular
hydrogen bond, there are several intermolecular hydrogen
bonds. It is interesting to note that there is no direct hydrogen
bond between the sildena®l molecules, but the citrate anions
function as a link between them. The water molecule does not
act as an acceptor but just as a donor to a citrate anion and to
sulfonyl atom O1 of a sildena®l cation (Table 2). The depro-
tonated carboxy group of the citrate molecule shows a
signi®cantly different geometry than the two other carboxyl
groups: the two CÐO bonds have the same length and the
OÐCÐO angle is enlarged (Table 1).
The cell parameters of sildena®l citrate without any solvent,
determined by powder diffraction (Melnikov et al., 2003), are
totally different from those of the title compound: a = 26.98 AÊ ,
b = 11.95 AÊ , c = 16.68 AÊ , and  = 106.96 V = 5143.9 AÊ 3.
Experimental
Sildena®l citrate was obtained as a gift sample from CIPLA, Mumbai,
India, and used without further puri®cation. Recrystallization from
dimethylformamide yielded needles of (I) after slow evaporation of
the solvent. The title compound melts at 460 K. IR (KBr,  cmÿ1):
3616 (m), 3478 (m), 3300 (s), 3029 (m), 2962 (m), 2870 (m), 2563 (w),
2362 (m), 1702 (vs), 1581 (s), 1491 (m), 1462 (m), 1394 (m), 1359 (m),
1280 (m), 1250 (m), 1172 (s), 1096 (w), 1027 (m), 995 (s), 940 (m), 808
(m), 736 (s), 690 (m), 657 (m), 617 (m), 588 (s), 557 (m); 1H NMR
(DMSO-d6, p.p.m.): 0.86±0.90 (t, 3H, CH3±), 1.27±1.31 (t, 3H, CH3Ð),
1.64±1.73 (m, 2H, CH2Ð), 2.29 (s, 4H, CH2Ð), 2.55±2.75 (t, 2H,
CH2Ð), 2.96 (bs, 1H, NHÐ), 3.94 (bm, 13H, NÐCHÐ), 4.11±4.2 (s,
3H, N+ÐCH3Ð), 7.34±7.36 (d, 1H, ArHÐ), 7.79±7.83 (d, 2H, ArHÐ
), 12.19 (bs, 1H, N+HÐ); 13C NMR (DMSO-d6, p.p.m.): 14.24 (q, C42,
CH3Ð), 14.67 (q, C29, CH3Ð), 22.13 (t, C41, CH2Ð), 27.53 (t, C2,
CH2Ð), 38.3 (t, C40, CH2Ð), 39.1±40.35 (t, C12,C13,C15,C16, CH2Ð
), 43.64 (q, C37, CH3Ð), 44.71 (d, C35, C CÐ), 53.34 (d, C34,
C CÐ), 65.39 (t, C28, CH2Ð), 72.59 (q, C17, CH3Ð), 124.03
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Figure 1
Perspective view of the title compound, with the atom numbering;
displacement ellipsoids are drawn at the 30% probability level.
Figure 2
Least-squares ®t of sildena®l (open bonds) and isosildena®l (closed
bonds). The benzene ring, the SO2 group and the piperazine ring were
®tted (r.m.s. deviation = 0.122 AÊ ).
(d, C26, ArCHÐ), 124.82 (d, C22, ArCHÐ), 126.52 (s, C23), 130.43
(d, C25, ArCHÐ), 132.02 (s, C24, ArCÐ), 138.18 (s, C21, ArC),
145.45 (s, C39, C NÐ), 148.55 (s, C6, COOÿÐ), 154.24 (s, C5,
HOOCÐ), 160.45 (s, C33, C O±), 171.87 (s, C31), 175.81 (s, C3,
citrate CÐ). Analysis calculated for C28H40N6O12S: C 49.11, H 5.89,
N 12.27%; found: C 49.31, H 5.81, N 12.4%.
Crystal data
C22H31N6O4S
+C6H7O7ÿH2O
Mr = 684.72
Orthorhombic, Pbca
a = 24.002 (4) AÊ
b = 10.9833 (17) AÊ
c = 24.364 (3) AÊ
V = 6422.9 (17) AÊ 3
Z = 8
Dx = 1.416 Mg m
ÿ3
Mo K radiation
Cell parameters from 8732
re¯ections
 = 2.0±23.1
 = 0.17 mmÿ1
T = 173 (2) K
Rod, colourless
0.26  0.12  0.11 mm
Data collection
Stoe IPDS-II two-circle
diffractometer
! scans
Absorption correction: multi-scan
(MULABS; Spek, 2003;
Blessing, 1995)
Tmin = 0.937, Tmax = 0.951
44385 measured re¯ections
5856 independent re¯ections
1970 re¯ections with I > 2(I)
Rint = 0.098
max = 25.4

h = ÿ28! 28
k = ÿ13! 13
l = ÿ29! 27
Refinement
Re®nement on F 2
R[F 2 > 2(F 2)] = 0.079
wR(F 2) = 0.154
S = 0.78
5856 re¯ections
428 parameters
H-atom parameters constrained
w = 1/[2(Fo
2) + (0.0407P)2]
where P = (Fo
2 + 2Fc
2)/3
(/)max < 0.001
max = 0.38 e AÊ
ÿ3
min = ÿ0.42 e AÊ ÿ3
Table 1
Selected geometric parameters (AÊ , ).
S1ÐO1 1.428 (4)
S1ÐO2 1.443 (4)
S1ÐN11 1.630 (5)
N11ÐC16 1.470 (7)
N11ÐC12 1.485 (6)
C13ÐN14 1.507 (7)
N14ÐC17 1.486 (7)
N14ÐC15 1.504 (7)
C31ÐN36 1.295 (7)
C31ÐN32 1.383 (7)
N32ÐC33 1.367 (7)
C33ÐC34 1.447 (8)
C34ÐN37 1.359 (7)
C34ÐC35 1.385 (8)
C35ÐN36 1.361 (7)
C35ÐC39 1.417 (8)
N37ÐN38 1.352 (6)
N37ÐC37 1.450 (7)
C1ÐO11 1.204 (7)
C1ÐO12 1.293 (7)
C3ÐO3 1.423 (6)
C5ÐO51 1.224 (8)
C5ÐO52 1.318 (8)
C6ÐO61 1.258 (7)
C6ÐO62 1.259 (7)
O11ÐC1ÐO12 120.6 (7)
O51ÐC5ÐO52 119.9 (7)
O61ÐC6ÐO62 126.3 (6)
Table 2
Hydrogen-bonding geometry (AÊ , ).
DÐH  A DÐH H  A D  A DÐH  A
N14ÐH14  O3 0.93 1.88 2.764 (6) 159
N14ÐH14  O62 0.93 2.30 2.911 (6) 123
N32ÐH32  O27 0.88 1.94 2.622 (6) 134
O12ÐH12  N38i 0.84 1.98 2.771 (7) 157
O3ÐH3  O61ii 0.84 1.77 2.605 (5) 173
O52ÐH52  O62ii 0.84 1.73 2.490 (6) 149
O1WÐH1WA  O1iii 0.84 2.11 2.946 (13) 179
O1WÐH1WB  O51 0.84 1.84 2.678 (16) 179
Symmetry codes: (i) 1ÿ x; 2ÿ y; 1ÿ z; (ii) 32ÿ x; yÿ 12; z; (iii) 12 x; y; 12ÿ z.
H atoms were located in a difference map, positioned geom-
etrically and re®ned with ®xed individual displacement parameters
[set to 1.2 times Ueq value of the parent atom (1.5 for methyl groups)]
using a riding model, with NÐH = 0.88 AÊ , OÐH = 0.84 AÊ and CÐH
distances ranging from 0.93 to 0.99 AÊ . In addition, the torsion angles
about the hydroxyl groups and the methyl group at the pyrazolo-
pyrimidone ring system were re®ned.
Data collection: X-AREA (Stoe & Cie, 2001); cell re®nement:
X-AREA; data reduction: X-AREA; program(s) used to solve
structure: SHELXS97 (Sheldrick, 1990); program(s) used to re®ne
structure: SHELXL97 (Sheldrick, 1997); molecular graphics: XP in
SHELXTL-Plus (Sheldrick, 1991); software used to prepare material
for publication: SHELXL97.
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